SCHEMBL19397291

SCHEMBL19397291

O=C1CC2(CCNCC2)CN1c1ccncc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
CYP2D6 P10635 3/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2C19 P33261 2/20 0.51
TSHR P16473 2/20 0.51
CYP2C9 P11712 1/20 0.51
HPGD P15428 3/20 0.42
ADRB2 P07550 1/20 0.41
NCF1 P14598 1/20 0.41
PLD1 Q13393 1/20 0.41
ACACA Q13085 5/20 0.40
ACACB O00763 3/20 0.40
HSD17B10 Q99714 2/20 0.37
CYP1A2 P05177 1/20 0.37
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3229055 0.83 TSHR (0.54) ALDH1A1CYP2D6CYP3A4CYP2C19TSHR
SCHEMBL10111316 0.82 TMEM97 (0.47) ALDH1A1CYP2D6CYP3A4TSHRHPGD
SCHEMBL16430910 0.79 ACACA (0.48) ALDH1A1CYP2D6CYP3A4TSHRHPGD
SCHEMBL30327875 0.78 AR (0.45) ALDH1A1CYP2D6CYP3A4CYP2C19TSHR
SCHEMBL17723673 0.78 CYP17A1 (0.40) ALDH1A1CYP2D6CYP3A4CYP2C19TSHR
SCHEMBL16438716 0.77 KCNJ1 (0.46) ALDH1A1CYP2D6CYP3A4TSHRHPGD
Hydrochloric Acid SCHEMBL30328059 0.77 AR (0.44) ALDH1A1CYP2D6CYP3A4CYP2C19TSHR
Hydrochloric Acid SCHEMBL30327714 0.76 CHRNB2 (0.48) ALDH1A1CYP2D6CYP3A4CYP2C19TSHR
Hydrochloric Acid SCHEMBL16431012 0.76 KCNJ1 (0.45) TSHRACACAITGB3ITGA2B
SCHEMBL17723444 0.75 KCNJ1 (0.44) ALDH1A1CYP2D6CYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275298-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL WUXI APPTEC (SHANGHAI) CO., LTD. (CN) 2017-09-28 US disclosed
US-20170275298-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL WUXI APPTEC (SHANGHAI) CO., LTD. (CN) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275298-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL KCNJ11, KCNJ1, KCNJ2 ALDH1A1 1722/4885CYP2D6 3517/4885CYP3A4 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.